Back to companies

Quince Therapeutics Inc: Executives

The following section provides information on Quince Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Quince Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

David Lamond

Chairman Executive Board Since: 2015 Age: 48

Dirk Thye

Chief Executive Officer; Director Executive Board Since: 2022 Age: 53

Karen Smith

Chief Medical Officer Senior Management Since: 2022 Age: 55

Charles S. Ryan, Ph.D

President Senior Management Since: 2023

Brendan Hannah

Chief Business Officer; Principal Financial Officer Senior Management Since: 2022 Age: 38
Gain a 360-degree view of Quince Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Quince Therapeutics Inc and make more informed decisions for your business Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code